Global Medical Cannabis
Market Report
2025
Medical Cannabis Market Report 2025 (Global Edition)
The global medical cannabis market size will be USD 21458.9 million in 2025. Rising research and patient demand is expected to boost sales to USD 116129.6499 million by 2033, with a Compound Annual Growth Rate (CAGR) of 23.50% from 2025 to 2033.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Medical Cannabis Market Report 2025.
Global Medical Cannabis Market Report 2025 Market Size Split by Derivative Outlook: (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others), by Application Outlook: (Mental Health Management, Neurolog...
According to Cognitive Market Research, the global medical cannabis market size will be USD 21458.9 million in 2025. It will expand at a compound annual growth rate (CAGR) of 23.50% from 2025 to 2033.
- North America held the major market share for more than 40% of the global revenue with a market size of USD 7939.79 million in 2025 and will grow at a compound annual growth rate (CAGR) of 22.1% from 2025 to 2033.
- Europe accounted for a market share of over 30% of the global revenue with a market size of USD 6223.08 million.
- APAC held a market share of around 23% of the global revenue with a market size of USD 5150.14 million in 2025 and will grow at a compound annual growth rate (CAGR) of 26.5% from 2025 to 2033.
- South America has a market share of more than 5% of the global revenue with a market size of USD 815.44 million in 2025 and will grow at a compound annual growth rate (CAGR) of 23.9% from 2025 to 2033.
- The Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 858.36 million in 2025 and will grow at a compound annual growth rate (CAGR) of 24.1% from 2025 to 2033.
- Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 472.10 million in 2025 and will grow at a compound annual growth rate (CAGR) of 23.1% from 2025 to 2033.
- Mental health management category is the fastest-growing segment of the medical cannabis industry.
| 2024 | 2025 | 2032 | 2033 | CAGR | |
|---|---|---|---|---|---|
| Global Medical Cannabis Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 9.14% |
| Base Year | 2024 |
| Historical Data Time Period | 2021-2024 |
| Forecast Period | 2025-2033 |
| Market Split by Derivative Outlook: |
|
| Market Split by Application Outlook: |
|
| Market Split by Route of Administration Outlook: |
|
| Market Split by Distribution Channel Outlook: |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
| |
Report scope is customizable as we have a huge database of Medical Cannabis industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Medical Cannabis Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Medical Cannabis Market Report Description
Introduction of the Medical Cannabis Market
Medical cannabis is cannabis that is used therapeutically to reduce the symptoms of a variety of illnesses. It usually consists of substances like tetrahydrocannabinol and cannabidiol, which are given under a doctor's supervision in controlled forms like oils, pills, and vaporized formulations. The medicinal cannabis industry is being driven by progressive regulatory improvements that enhance patient access and expand legalization. Moreover, the market is expanding as a result of rising patient demand for alternative therapies and increased confidence among medical professionals due to scientific studies verifying its therapeutic benefits. Furthermore, large investments in state-of-the-art farming and processing technologies are also creating opportunities for product innovation and diversity, creating a dynamic environment with a lot of opportunities for company growth.
In February 2025, Canopy Growth Corporation, a global cannabis leader committed to utilizing cannabis to enhance lives, formally introduced its Tweed brand in the German medical cannabis market. This includes the availability of four new Tweed strains cultivated in the EU through a partnership with Gro-Vida S.A., a Portuguese medical cannabis grower. https://www.canopygrowth.com/investors/news-releases/canopy-growth-announces-entry-of-tweed-brand-to-german-medical-cannabis-market/
Medical Cannabis Market Size
Market Dynamics of Medical Cannabis Market
Key Drivers for Medical Cannabis Market
Increasing Patient Demand and Awareness to Boost Market Growth
The market for medical cannabis is expanding due in large part to rising patient demand and awareness. The need for alternative therapies keeps growing as more people learn about the therapeutic advantages of cannabis, especially in the treatment of neurological disorders, anxiety, and chronic pain. Moreover, patients and healthcare professionals are becoming more accepting of cannabis-based treatments as a result of educational programs, clinical studies, and success stories. As a result of this increased knowledge and the trend toward natural, non-addictive treatments, the patient base is rising, which will support the market’s expansion in the upcoming years. For instance, in February 2025, Cronos Group Inc., an innovative global cannabinoid firm, announced the launch of Lord Jones® Chocolate Fusions, its exciting first entrance into the chocolate edibles sector. A skilled group of chefs, food scientists, and cannabis product development leaders created and designed Cronos’ most recent edible breakthrough.
Advancements in Technology to Boost Market Growth
Technological developments are mostly driving the market expansion for medical cannabis. Innovations such as nanotechnology boost the absorption and efficacy of cannabinoids, leading to faster and more dependable therapeutic effects. Additionally, digital platforms and AI-driven technologies promote tailored treatment plans, increasing patient results and fostering broader acceptance of medical cannabis. According to forecasts, the cannabis technology industry in North America is expanding at a compound annual growth rate of 22.1% between 2024 and 2030. As a result, these technical developments strengthen the position of medical cannabis in contemporary healthcare by standardizing products, improving quality control, and streamlining distribution. ?
Restraint Factor for the Medical Cannabis Market
High Manufacturing Costs Will Limit Market Growth
One major obstacle to the expansion of the medicinal cannabis business is the high cost of manufacturing. The cost of growing dried flowers varies depending on the method. Moreover, additional costs associated with labelling, testing, packaging, and security measures are brought about by regulatory compliance. For example, manufacturers’ yearly regulatory expenditures in North America are anticipated to be high for medical cannabis shops. Higher product pricing results from these increased expenses, which could restrict patient access and impede market growth. Furthermore, resolving these financial issues is essential to developing a medicinal cannabis market that is accessible and long-lasting, especially in emerging markets.
Market Trends in Medical Cannabis Market
Rising Mental Health Management Sector
The market for medical cannabis is expanding due in large part to the growing mental health management industry. Demand for cannabis-based medicines is rising as more people become aware of the potential therapeutic benefits of cannabis, particularly in the treatment of mental health issues like anxiety, depression, PTSD, and insomnia. Additionally, because it has fewer adverse effects and a lower risk of addiction than traditional pharmaceuticals, cannabis—in particular, cannabidiol is becoming more and more popular as an alternative. Moreover, as more individuals and medical professionals investigate cannabis as a potential therapy option, this trend is anticipated to grow up speed in the upcoming period.
Growing Investment and Strategic Collaborations
The growth of the medicinal cannabis sector is being greatly aided by increasing investments and strategic partnerships. Large companies have made significant investments in cannabis businesses, which have improved product development and market reach. Moreover, the purchase of MedReleaf by Aurora Cannabis also increased its production capacity and worldwide reach. Standardizing cultivation methods is the goal of cooperative projects like the medicinal cannabis professionalization & innovation research project, which guarantees constant quality and effectiveness. As a result, these alliances and investments increase market accessibility, stimulate innovation, and improve product options, all of which contribute to the medical cannabis industry’s strong growth.
We have various report editions of Medical Cannabis Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Impact of Tariff Trumph on Pharmaceuticals Industry
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
Competitive Landscape of the Medical Cannabis Market
The market for medical cannabis is highly competitive, with a wide range of competitors, from well-known pharmaceutical firms to up-and-coming entrepreneurs, gaining market share; many businesses concentrate on developing innovative products, utilizing cutting-edge extraction technologies, and increasing their geographic reach. Furthermore, companies frequently engage in strategic alliances, mergers, and acquisitions as they work to fortify their portfolios and satisfy changing regulatory standards. Moreover, competition is encouraged in this dynamic environment, which leads to quality improvements, advances in research, and the creation of novel therapeutic applications to meet a range of consumer needs.
In February 2025, Cronos Group Inc. will add innovations to its Lord Jones® brand portfolio to strengthen its selection of high-end cannabis products in the Canadian market. The Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes, which are currently offered all over Canada, include new cultivars. https://ir.thecronosgroup.com/news-releases/news-release-details/lord-jonesr-live-resin-vapes-and-ice-water-hash-pre-rolls-now In October 2024, Acreage Holdings, Inc. and Canopy Growth Corporation confirmed that Canopy USA, LLC has completed its acquisition of Acreage. Canopy USA now owns all of Acreage’s issued and outstanding shares. https://www.canopygrowth.com/investors/news-releases/canopy-growth-and-acreage-confirm-canopy-usas-completed-acquisition-of-acreage/ In November 2024, Medical Marijuana, Inc., the first publicly traded cannabis company in the United States to launch the world’s first cannabis-derived nutraceutical products, brands, and supply chain, announced that its subsidiary HempMeds® Mexico worked with experts from the Autonomous University of Barcelona, Spain, and the Meritorious Autonomous University of Puebla, Mexico, to conduct a new study that demonstrates the benefits of CBD in treating Parkinson’s disease. https://medicalmarijuanainc.com/2022/10/12/medical-marijuana-inc-subsidiary-hempmeds-mexico-participates-in-research-finding-promising-therapeutic-benefits-of-cbd-in-parkinsons-disease-treatment/
Top Companies Market Share in Medical Cannabis Industry: (In no particular order of Rank)
- Canopy Growth Corporation
- United Cannabis
- Aurora Cannabis
- Cannabis Sativa
- Inc.
- Emerald Health Therapeutics
- GW Pharmaceuticals plc
- Tilray
- Medical Marijuana
- Inc.
- The Supreme Cannabis Company
- Inc.
- The Cronos Group
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of the Medical Cannabis Market
Which Region Dominates the Medical Cannabis Market in 2025?
According to Cognitive Market Research, North America currently dominates the medical cannabis market, and the region is expected to have significant growth during the projected period. This growth is driven by growing patient awareness, progressive regulatory support, expanding legalization, and an increasing amount of clinical research confirming its therapeutic effects. Furthermore, market expansion in the region is further accelerated by smart mergers and acquisitions, as well as investments in cutting-edge cultivation and processing technology, which are major growth drivers in the market for medical cannabis.
Which Region is Expanding at the Fastest CAGR?
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR) propelled by growing government programs for medicinal cannabis research, growing uptake in developing nations, and technological advancements. Furthermore, this strong regional development is also a result of growing investments in regional production facilities, strategic alliances, and increased consumer knowledge of cannabis-based treatments, which have fueled market expansion in the company years.
The current report Scope analyzes Medical Cannabis Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Medical Cannabis Market Share (%) by Region (2021-2033)
Medical Cannabis Market Share (%) by Country
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
North America Medical Cannabis
According to Cognitive Market Research, the global Medical cannabis market size was estimated at USD 21458.9 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 7939.79 million in 2025 and will grow at a compound annual growth rate (CAGR) of 22.1% from 2025 to 2033.
United States Medical cannabis market size is USD 6264.50 million in 2025
According to Cognitive Market Research, the US had a major share in the Medical cannabis market with a market size of USD 6264.50 million in 2025 and is projected to grow at a CAGR of 22.1% during the forecast period. The U.S. Market's rising investment in new technology.
Canada Medical cannabis market size is USD 952.78 million in 2025
The Canadian Medical cannabis market had a market share of USD 952.78 million in 2025 and is projected to grow at a CAGR of 22.9% during the forecast period. Canada’s increasing healthcare expenditure.
Mexico Medical cannabis market size is USD 722.52 million in 2025
The Mexico Medical cannabis market is projected to witness growth at a CAGR of 22.7% during the forecast period, with a market size of USD 722.52 million in 2025..
Europe Medical Cannabis
According to Cognitive Market Research, the global Medical cannabis market size was estimated at USD 21458.9 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 6223.08 million in 2025 and will grow at a compound annual growth rate (CAGR) of 22.4? from 2025 to 2033.
United Kingdom Medical cannabis market size is USD 1045.48 million in 2025
The United Kingdom Medical cannabis market had a market share of USD 1045.48 million in 2025 and is projected to grow at a CAGR of 23.2% during the forecast period. In the UK, Medical cannabis sales witnessed an upswing due to supportive government policies.
France Medical cannabis market size is USD 572.52 million in 2025
The France medical cannabis market is projected to witness growth at a CAGR of 21.6% during the forecast period, with a market size of USD 572.52 million in 2025.
Germany Medical cannabis market size is USD 1232.17 million in 2025
According to Cognitive Market Research, the German Medical cannabis market size was valued at USD 1232.17 million in 2025 and is projected to grow at a CAGR of 22.7% during the forecast period. In Germany, advancements in cultivation technology.
Italy Medical cannabis market size is USD 535.18 million in 2025
The Italy Medical cannabis market is projected to witness growth at a CAGR of 21.8% during the forecast period, with a market size of USD 535.18 million in 2025.
Russia Medical cannabis market size is USD 964.58 million in 2025
The Russian medical cannabis market is projected to witness growth at a CAGR of 21.4% during the forecast period, with a market size of USD 964.58 million in 2025
Spain Medical cannabis market size is USD 510.29 million in 2025
The Spain Medical cannabis market is projected to witness growth at a CAGR of 21.5% during the forecast period with a market size of USD 510.29 million in 2025
Sweden Medical cannabis market size is USD 192.92 million in 2025
The Sweden Medical cannabis market is projected to witness growth at a CAGR of 22.5% during the forecast period, with a market size of USD 192.92 million in 2025.
Denmark Medical cannabis market size is USD 130.68 million in 2025
The Denmark Medical cannabis market is projected to witness growth at a CAGR of 22.1% during the forecast period, with a market size of USD 130.68 million in 2025
Switzerland Medical cannabis market size is USD 93.35 million in 2025
The Switzerland Medical cannabis market is projected to witness growth at a CAGR of 22.1% during the forecast period, with a market size of USD 93.35 million in 2025.
Luxembourg Medical cannabis market size is USD 74.68 million in 2025
The Luxembourg Medical cannabis market is projected to witness growth at a CAGR of 22.7% during the forecast period, with a market size of USD 74.68 million in 2025.
Rest of Europe Medical cannabis market size is USD 871.23 million in 2025
The Rest of Europe's Medical cannabis market is projected to witness growth at a CAGR of 21.1% during the forecast period, with a market size of USD 871.23million in 2025.
Asia Pacific Medical Cannabis
According to Cognitive Market Research, the global Medical cannabis market size was estimated at USD 21458.9 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 5150.14 million in 2025 and will grow at a compound annual growth rate (CAGR) of 26.5% from 2025 to 2033.
China Medical cannabis market size is USD 2163.06 million in 2025
According to Cognitive Market Research, the China Medical cannabis market size was valued at USD 2163.06 million in 2025 and is projected to grow at a CAGR of 26.0% during the forecast period. Medical cannabis surged in China due to major market players.
Japan Medical cannabis market size is USD 710.72 million in 2025
The Japan Medical cannabis market is projected to witness growth at a CAGR of 25.0% during the forecast period, with a market size of USD 710.72 million in 2025
South Korea Medical cannabis market size is USD 618.02 million in 2025
The South Korean Medical cannabis market had a market share of USD 618.02 million in 2025 and is projected to grow at a CAGR of 24.7% during the forecast period. India's increasing hospital pharmacies sector.
India Medical cannabis market size is USD 515.01 million in 2025
The Indian Medical cannabis market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 515.01 million in 2025.
Australian Medical cannabis market size is USD 267.81 million in 2025
The Australian Medical cannabis market is projected to witness growth at a CAGR of 24.8% during the forecast period, with a market size of USD 267.81 million in 2025.
Singapore Medical cannabis market size is USD 103.00 million in 2025
The Singapore Medical cannabis market is projected to witness growth at a CAGR of 26.8% during the forecast period, with a market size of USD 103.00 million in 2025.
Taiwan Medical cannabis market size is USD 200.86 million in 2025
The Taiwan Medical cannabis market is projected to witness growth at a CAGR of 23.0% during the forecast period, with a market size of USD 200.86 million in 2025.
South East Asia Medical cannabis market size is USD 339.91 million in 2025
The South East Asia Medical cannabis market is projected to witness growth at a CAGR of 27.3% during the forecast period, with a market size of USD 339.91 million in 2025.
Rest of APAC Medical cannabis market size is USD 231.76 million in 2025
The Rest of APAC Medical cannabis market is projected to witness growth at a CAGR of 26.3% during the forecast period, with a market size of USD 231.76 million in 2025.
South America Medical Cannabis
According to Cognitive Market Research, the global Medical cannabis market size was estimated at USD 21458.9 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 815.44 million in 2025 and will grow at a compound annual growth rate (CAGR) of 23.9% from 2025 to 2033.
Brazil Medical cannabis market size is USD 349.01 million in 2025
According to Cognitive Market Research, the Brazil Medical cannabis market size was valued at USD 349.01 million in 2025 and is projected to grow at a CAGR of 24.6% during the forecast period. Medical cannabis flourished in Brazil due to the expanding epilepsy sector.
Argentina Medical cannabis market size is USD 82.07 million in 2025
Argentina's Medical cannabis market had a market share of USD 82.07 million in 2025 and is projected to grow at a CAGR of 24.8% during the forecast period. Argentina's increasing consumer awareness.
Colombia Medical cannabis market size is USD 72.57 million in 2025
Colombia Medical cannabis market is projected to witness growth at a CAGR of 23.7% during the forecast period, with a market size of USD 72.57 million in 2025
Peru Medical cannabis market size is USD 66.87 million in 2025
Peru Medical cannabis market is projected to witness growth at a CAGR of 24.0% during the forecast period, with a market size of USD 66.87 million in 2025.
Chile Medical cannabis market size is USD 58.71 million in 2025
Chile Medical cannabis market is projected to witness growth at a CAGR of 24.2% during the forecast period, with a market size of USD 58.71 million in 2025
Rest of South America Medical cannabis market size is USD 131.29 million in 2025
The Rest of South America's Medical cannabis market is projected to witness growth at a CAGR of 23.0% during the forecast period, with a market size of USD 131.29 million in 2025.
Middle East Medical Cannabis
According to Cognitive Market Research, the global Medical cannabis market size was estimated at USD 21458.9 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 858.36 million in 2025 and will grow at a compound annual growth rate (CAGR) of 24.1% from 2025 to 2033..
Qatar Medical cannabis market size is USD 68.67 million in 2025
The Qatar Medical cannabis market is projected to witness growth at a CAGR of 23.6% during the forecast period, with a market size of USD 68.67 million in 2025. Medical cannabis sales flourish due to the increasing investments in advanced medical technology.
Saudi Arabia Medical cannabis market size is USD 302.14 million in 2025
The Saudi Arabia Medical cannabis market is projected to witness growth at a CAGR of 24.4% during the forecast period, with a market size of USD 302.14 million in 2025.
Turkey Medical cannabis market size is USD 68.67 million in 2025
The Turkey Medical cannabis market is projected to witness growth at a CAGR of 24.7% during the forecast period, with a market size of USD 68.67 million in 2025. Medical cannabis sales flourished in Turkey due to growing demand for online pharmacies
UAE Medical cannabis market size is USD 176.82 million in 2025
The UAE Medical cannabis market is projected to witness growth at a CAGR of 24.6% during the forecast period, with a market size of USD 176.82 million in 2025.
Egypt Medical cannabis market size is USD 51.50 million in 2025
The Egypt Medical cannabis market is projected to witness growth at a CAGR of 23.9% during the forecast period, with a market size of USD 51.50 million in 2025.
Rest of the Middle East Medical cannabis market size is USD 190.56 million in 2025
The Rest of the Middle East Medical cannabis market is projected to witness growth at a CAGR of 23.3% during the forecast period, with a market size of USD 190.56 million in 2025
Africa Medical Cannabis
According to Cognitive Market Research, the global Medical cannabis market size was estimated at USD 21458.9 million, out of which Africa held the major market share of around 2% of the global revenue with a market size of USD 472.10 million in 2025 and will grow at a compound annual growth rate (CAGR) of 23.1% from 2025 to 2033..
Nigeria Medical cannabis market size is USD 37.77 million in 2025
The Nigeria Medical cannabis market is projected to witness growth at a CAGR of 23.3% during the forecast period, with a market size of USD 37.77 million in 2025. Medical cannabis sales flourish due to the innovative technology.
South African Medical cannabis market size is USD 166.18 million in 2025
The South Africa Medical cannabis market is projected to witness growth at a CAGR of 24.0% during the forecast period, with a market size of USD 166.18 million in 2025.
Rest of Africa Medical cannabis market size is USD 268.15 million in 2025
The Rest of Africa’s Medical cannabis market is projected to witness growth at a CAGR of 22.3% during the forecast period, with a market size of USD 268.15 million in 2025.
Medical Cannabis Market Analysis
Global Medical Cannabis Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Medical Cannabis Industry growth. Medical Cannabis market has been segmented with the help of its Derivative Outlook:, Application Outlook: Route of Administration Outlook:, and others. Medical Cannabis market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Medical Cannabis Market?
Medical Cannabis Market Derivative Segment Analysis
According to Cognitive Market Research, cannabidiol (CBD) are likely to dominate the medical cannabis market. This is due to its many medicinal uses and low levels of psychotropic effects. Its efficacy in treating ailments like inflammation, anxiety, and epilepsy is well-supported by studies. Additionally, CBD’s market expansion is further supported by the rising customer desire for safer, natural substitutes, changing legal frameworks, and cutting-edge product advancements.
Tetrahydrocannabinol are the fastest-growing segment in the medical cannabis market. This growth is because of its strong therapeutic effects, especially in raising appetite, reducing nausea, and managing pain in cancer patients. Demand for THC-based goods has been fueled by growing research into its potential medical advantages as well as regional legality and acceptance of these items. Moreover, the creation of novel THC-infused products and therapies, including edibles, tinctures, and oils, also contributes to the market’s expansion, ensuring their steady growth in the forecast period.
Medical Cannabis Market Share (%) by Derivative Outlook: in 2021-2033
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Medical Cannabis Industry. Request a Free Sample PDF!
Medical cannabis Market Application Segment Analysis
According to Cognitive Market Research, the neurological disorders management application segment holds the largest share of the market. This is due to the fact that cannabis, especially CBD and THC, has demonstrated great potential in the treatment of diseases like chronic pain and multiple sclerosis. The demand is driven by mounting evidence of the effectiveness of cannabis-based treatments for neurological conditions, as well as rising patient awareness and doctor recommendations. Additionally, the growing incidence of neurological conditions and the creation of focused cannabis-based therapies also support this market segment’s leading position.
In the medical cannabis market, the mental health management segment has been expanding at a rapid pace because there is growing evidence that cannabis, and CBD in particular, is useful in treating problems like sleeplessness, PTSD, depression, and anxiety. Additionally, cannabis-based treatments for mental health illnesses are becoming more and more popular among patients due to growing awareness of their therapeutic benefits and the fact that they have fewer negative effects than standard pharmaceuticals also fuels market expansion.
Medical Cannabis Market Share (%) by Application Outlook: in 2021-2033
2021
2025
2033
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Medical Cannabis Route of Administration Outlook: Segment Analysis
Medical Cannabis Market Route of Administration Segment Analysis
According to Cognitive Market Research, the nasal segment holds the largest market share. Because of its quick-acting and efficient delivery system, nasal sprays allow cannabinoids like CBD and THC to be quickly absorbed into the bloodstream, providing immediate relief for conditions like pain, anxiety, and nausea. Moreover, nasal products’ convenience, simplicity, and non-invasiveness all contribute to their rising popularity, making them a popular choice for patients looking for discreet and effective treatment options, which encourages high adoption.
In the medical cannabis market, the rapidly growing sector is the oral is driven by consumers’ growing desire for discrete and easy ways to consume. Capsules, sweets, and tinctures are examples of oral forms that provide accurate dosing, convenience, and longer-lasting benefits. Moreover, oral cannabis treatments are becoming more and more popular, especially for treating chronic pain, anxiety, and sleep issues, as patient knowledge grows and new products hit the market, positioning this route of administration as the fastest-growing in the segment.
- Nasal
- Oral
- Others
Medical Cannabis Distribution Channel Outlook: Segment Analysis
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Conclusion
- The global medical cannabis market will expand significantly by 23.50% CAGR between 2025 and 2033.
- Cannabidiol (CBD) is expected to dominate the medical cannabis market over the forecast period. Due to their wide range of therapeutic uses, low levels of psychoactivity, and safer, non-intoxicating qualities.
- Neurological disorders management holds the largest market share in the distribution channel segment because of strong clinical evidence, the growing frequency of diseases like multiple sclerosis and epilepsy, and the growing use of cannabis-based treatments.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Medical Cannabis Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Medical Cannabis Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Derivative Outlook: | Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others |
| Application Outlook: | Mental Health Management, Neurological Disorders Management, Pain Management |
| Route of Administration Outlook: | Nasal, Oral, Others |
| Distribution Channel Outlook: | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
| List of Competitors | Canopy Growth Corporation, United Cannabis, Aurora Cannabis, Cannabis Sativa, Inc., Emerald Health Therapeutics, GW Pharmaceuticals plc, Tilray, Medical Marijuana, Inc., The Supreme Cannabis Company, Inc., The Cronos Group |
This chapter will help you gain GLOBAL Market Analysis of Medical Cannabis. Further deep in this chapter, you will be able to review Global Medical Cannabis Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Medical Cannabis Revenue Market Size, Trend Analysis 2021 - 2033
-
1.2 Global Medical Cannabis Market Size By Regions 2021 - 2033
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Medical Cannabis Revenue Market Size By Region
-
-
1.3 Global Medical Cannabis Market Size By Derivative Outlook: 2021 - 2033
-
1.3.1 Cannabidiol (CBD) Market Size
-
1.3.2 Tetrahydrocannabinol (THC) Market Size
-
1.3.3 Others Market Size
-
-
1.4 Global Medical Cannabis Market Size By Application Outlook: 2021 - 2033
-
1.4.1 Mental Health Management Market Size
-
1.4.2 Neurological Disorders Management Market Size
-
1.4.3 Pain Management Market Size
-
-
1.5 Global Medical Cannabis Market Size By Route of Administration Outlook: 2021 - 2033
-
1.5.1 Nasal Market Size
-
1.5.2 Oral Market Size
-
1.5.3 Others Market Size
-
-
1.6 Global Medical Cannabis Market Size By Distribution Channel Outlook: for 2021 - 2033
-
1.6.1 Hospital Pharmacies Market Size
-
1.6.2 Retail Pharmacies Market Size
-
1.6.3 Online Pharmacies Market Size
-
-
1.7 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.8 Executive Summary Global Market (2021 vs 2025 vs 2033)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.8.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
-
1.8.2 Global Market Revenue Split By Derivative Outlook:
-
1.8.3 Global Market Revenue Split By Application Outlook:
-
1.8.4 Global Market Revenue Split By Route of Administration Outlook:
-
1.8.5 Global Market Revenue Split By Distribution Channel Outlook:
-
1.8.6 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Medical Cannabis. Further deep in this chapter, you will be able to review North America Medical Cannabis Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Medical Cannabis Market Size 2021 - 2033
-
2.1.1 North America Medical Cannabis Market Size By Country 2021 - 2033
-
2.1.2 North America Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
2.1.2.1 North America Cannabidiol (CBD) Market Size
-
2.1.2.2 North America Tetrahydrocannabinol (THC) Market Size
-
2.1.2.3 North America Others Market Size
-
-
2.1.3 North America Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
2.1.3.1 North America Mental Health Management Market Size
-
2.1.3.2 North America Neurological Disorders Management Market Size
-
2.1.3.3 North America Pain Management Market Size
-
-
2.1.4 North America Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
2.1.4.1 North America Nasal Market Size
-
2.1.4.2 North America Oral Market Size
-
2.1.4.3 North America Others Market Size
-
-
2.1.5 North America Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
2.1.5.1 North America Hospital Pharmacies Market Size
-
2.1.5.2 North America Retail Pharmacies Market Size
-
2.1.5.3 North America Online Pharmacies Market Size
-
-
-
2.2 United States Market Size 2021 - 2033
-
2.2.1 United States Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
2.2.2 United States Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
2.2.3 United States Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
2.2.4 United States Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
2.3 Canada Market Size 2021 - 2033
-
2.3.1 Canada Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
2.3.2 Canada Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
2.3.3 Canada Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
2.3.4 Canada Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
2.4 Mexico Market Size 2021 - 2033
-
2.4.1 Mexico Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
2.4.2 Mexico Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
2.4.3 Mexico Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
2.4.4 Mexico Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
This chapter will help you gain Europe Market Analysis of Medical Cannabis. Further deep in this chapter, you will be able to review Europe Medical Cannabis Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Medical Cannabis Market Size 2021 - 2033
-
3.1.1 Europe Medical Cannabis Market Size By Country 2021 - 2033
-
3.1.2 Europe Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.1.2.1 Europe Cannabidiol (CBD) Market Size
-
3.1.2.2 Europe Tetrahydrocannabinol (THC) Market Size
-
3.1.2.3 Europe Others Market Size
-
-
3.1.3 Europe Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.1.3.1 Europe Mental Health Management Market Size
-
3.1.3.2 Europe Neurological Disorders Management Market Size
-
3.1.3.3 Europe Pain Management Market Size
-
-
3.1.4 Europe Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.1.4.1 Europe Nasal Market Size
-
3.1.4.2 Europe Oral Market Size
-
3.1.4.3 Europe Others Market Size
-
-
3.1.5 Europe Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
3.1.5.1 Europe Hospital Pharmacies Market Size
-
3.1.5.2 Europe Retail Pharmacies Market Size
-
3.1.5.3 Europe Online Pharmacies Market Size
-
-
-
3.2 United Kingdom Market Size 2021 - 2033
-
3.2.1 United Kingdom Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.2.2 United Kingdom Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.2.3 United Kingdom Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.2.4 United Kingdom Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.3 France Market Size 2021 - 2033
-
3.3.1 France Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.3.2 France Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.3.3 France Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.3.4 France Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.4 Germany Market Size 2021 - 2033
-
3.4.1 Germany Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.4.2 Germany Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.4.3 Germany Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.4.4 Germany Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.5 Italy Market Size 2021 - 2033
-
3.5.1 Italy Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.5.2 Italy Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.5.3 Italy Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.5.4 Italy Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.6 Russia Market Size 2021 - 2033
-
3.6.1 Russia Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.6.2 Russia Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.6.3 Russia Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.6.4 Russia Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.7 Spain Market Size 2021 - 2033
-
3.7.1 Spain Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.7.2 Spain Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.7.3 Spain Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.7.4 Spain Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.8 Sweden Market Size 2021 - 2033
-
3.8.1 Sweden Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.8.2 Sweden Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.8.3 Sweden Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.8.4 Sweden Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.9 Denmark Market Size 2021 - 2033
-
3.9.1 Denmark Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.9.2 Denmark Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.9.3 Denmark Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.9.4 Denmark Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.10 Switzerland Market Size 2021 - 2033
-
3.10.1 Switzerland Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.10.2 Switzerland Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.10.3 Switzerland Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.10.4 Switzerland Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.11 Luxembourg Market Size 2021 - 2033
-
3.11.1 Luxembourg Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.11.2 Luxembourg Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.11.3 Luxembourg Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.11.4 Luxembourg Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
3.12 Rest of Europe Market Size 2021 - 2033
-
3.12.1 Rest of Europe Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
3.12.2 Rest of Europe Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
3.12.3 Rest of Europe Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
3.12.4 Rest of Europe Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
This chapter will help you gain Asia Pacific Market Analysis of Medical Cannabis. Further deep in this chapter, you will be able to review Asia Pacific Medical Cannabis Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Medical Cannabis Market Size 2021 - 2033
-
4.1.1 Asia Pacific Medical Cannabis Market Size By Country 2021 - 2033
-
4.1.2 Asia Pacific Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.1.2.1 Asia Pacific Cannabidiol (CBD) Market Size
-
4.1.2.2 Asia Pacific Tetrahydrocannabinol (THC) Market Size
-
4.1.2.3 Asia Pacific Others Market Size
-
-
4.1.3 Asia Pacific Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.1.3.1 Asia Pacific Mental Health Management Market Size
-
4.1.3.2 Asia Pacific Neurological Disorders Management Market Size
-
4.1.3.3 Asia Pacific Pain Management Market Size
-
-
4.1.4 Asia Pacific Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.1.4.1 Asia Pacific Nasal Market Size
-
4.1.4.2 Asia Pacific Oral Market Size
-
4.1.4.3 Asia Pacific Others Market Size
-
-
4.1.5 Asia Pacific Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
4.1.5.1 Asia Pacific Hospital Pharmacies Market Size
-
4.1.5.2 Asia Pacific Retail Pharmacies Market Size
-
4.1.5.3 Asia Pacific Online Pharmacies Market Size
-
-
-
4.2 China Medical Cannabis Market Size 2021 - 2033
-
4.2.1 China Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.2.2 China Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.2.3 China Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.2.4 China Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
4.3 Japan Medical Cannabis Market Size 2021 - 2033
-
4.3.1 Japan Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.3.2 Japan Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.3.3 Japan Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.3.4 Japan Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
4.4 South Korea Medical Cannabis Market Size 2021 - 2033
-
4.4.1 South Korea Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.4.2 South Korea Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.4.3 South Korea Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.4.4 South Korea Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
4.5 India Medical Cannabis Market Size 2021 - 2033
-
4.5.1 India Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.5.2 India Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.5.3 India Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.5.4 India Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
4.6 Australia Medical Cannabis Market Size 2021 - 2033
-
4.6.1 Australia Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.6.2 Australia Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.6.3 Australia Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.6.4 Australia Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
4.7 Singapore Medical Cannabis Market Size 2021 - 2033
-
4.7.1 Singapore Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.7.2 Singapore Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.7.3 Singapore Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.7.4 Singapore Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
4.8 Taiwan Medical Cannabis Market Size 2021 - 2033
-
4.8.1 Taiwan Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.8.2 Taiwan Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.8.3 Taiwan Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.8.4 Taiwan Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
4.9 South East Asia Medical Cannabis Market Size 2021 - 2033
-
4.9.1 South East Asia Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.9.2 South East Asia Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.9.3 South East Asia Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.9.4 South East Asia Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
4.10 Rest of APAC Medical Cannabis Market Size 2021 - 2033
-
4.10.1 Rest of APAC Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
4.10.2 Rest of APAC Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
4.10.3 Rest of APAC Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
4.10.4 Rest of APAC Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
This chapter will help you gain South America Market Analysis of Medical Cannabis. Further deep in this chapter, you will be able to review South America Medical Cannabis Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Medical Cannabis Market Size 2021 - 2033
-
5.1.1 South America Medical Cannabis Market Size By Country 2021 - 2033
-
5.1.2 South America Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
5.1.2.1 South America Cannabidiol (CBD) Market Size
-
5.1.2.2 South America Tetrahydrocannabinol (THC) Market Size
-
5.1.2.3 South America Others Market Size
-
-
5.1.3 South America Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
5.1.3.1 South America Mental Health Management Market Size
-
5.1.3.2 South America Neurological Disorders Management Market Size
-
5.1.3.3 South America Pain Management Market Size
-
-
5.1.4 South America Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
5.1.4.1 South America Nasal Market Size
-
5.1.4.2 South America Oral Market Size
-
5.1.4.3 South America Others Market Size
-
-
5.1.5 South America Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
5.1.5.1 South America Hospital Pharmacies Market Size
-
5.1.5.2 South America Retail Pharmacies Market Size
-
5.1.5.3 South America Online Pharmacies Market Size
-
-
-
5.2 Brazil Medical Cannabis Market Size 2021 - 2033
-
5.2.1 Brazil Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
5.2.2 Brazil Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
5.2.3 Brazil Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
5.2.4 Brazil Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
5.3 Argentina Medical Cannabis Market Size 2021 - 2033
-
5.3.1 Argentina Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
5.3.2 Argentina Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
5.3.3 Argentina Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
5.3.4 Argentina Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
5.4 Colombia Medical Cannabis Market Size 2021 - 2033
-
5.4.1 Colombia Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
5.4.2 Colombia Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
5.4.3 Colombia Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
5.4.4 Colombia Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
5.5 Peru Medical Cannabis Market Size 2021 - 2033
-
5.5.1 Peru Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
5.5.2 Peru Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
5.5.3 Peru Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
5.5.4 Peru Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
5.6 Chile Medical Cannabis Market Size 2021 - 2033
-
5.6.1 Chile Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
5.6.2 Chile Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
5.6.3 Chile Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
5.6.4 Chile Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
5.7 Rest of South America Medical Cannabis Market Size 2021 - 2033
-
5.7.1 Rest of South America Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
5.7.2 Rest of South America Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
5.7.3 Rest of South America Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
5.7.4 Rest of South America Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
This chapter will help you gain Middle East Market Analysis of Medical Cannabis. Further deep in this chapter, you will be able to review Middle East Medical Cannabis Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
-
6.1 Middle East Medical Cannabis Market Size 2021 - 2033
-
6.1.1 Middle East Medical Cannabis Market Size By Country 2021 - 2033
-
6.1.2 Middle East Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
6.1.2.1 Middle East Cannabidiol (CBD) Market Size
-
6.1.2.2 Middle East Tetrahydrocannabinol (THC) Market Size
-
6.1.2.3 Middle East Others Market Size
-
-
6.1.3 Middle East Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
6.1.3.1 Middle East Mental Health Management Market Size
-
6.1.3.2 Middle East Neurological Disorders Management Market Size
-
6.1.3.3 Middle East Pain Management Market Size
-
-
6.1.4 Middle East Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
6.1.4.1 Middle East Nasal Market Size
-
6.1.4.2 Middle East Oral Market Size
-
6.1.4.3 Middle East Others Market Size
-
-
6.1.5 Middle East Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
6.1.5.1 Middle East Hospital Pharmacies Market Size
-
6.1.5.2 Middle East Retail Pharmacies Market Size
-
6.1.5.3 Middle East Online Pharmacies Market Size
-
-
-
6.2 Saudi Arabia Medical Cannabis Market Size 2021 - 2033
-
6.2.1 Saudi Arabia Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
6.2.2 Saudi Arabia Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
6.2.3 Saudi Arabia Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
6.2.4 Saudi Arabia Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
6.3 Turkey Medical Cannabis Market Size 2021 - 2033
-
6.3.1 Turkey Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
6.3.2 Turkey Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
6.3.3 Turkey Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
6.3.4 Turkey Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
6.4 UAE Medical Cannabis Market Size 2021 - 2033
-
6.4.1 UAE Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
6.4.2 UAE Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
6.4.3 UAE Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
6.4.4 UAE Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
6.5 Egypt Medical Cannabis Market Size 2021 - 2033
-
6.5.1 Egypt Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
6.5.2 Egypt Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
6.5.3 Egypt Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
6.5.4 Egypt Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
6.6 Qatar Medical Cannabis Market Size 2021 - 2033
-
6.6.1 Qatar Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
6.6.2 Qatar Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
6.6.3 Qatar Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
6.6.4 Qatar Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
6.7 Rest of Middle East Medical Cannabis Market Size 2021 - 2033
-
6.7.1 Rest of Middle East Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
6.7.2 Rest of Middle East Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
6.7.3 Rest of Middle East Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
6.7.4 Rest of Middle East Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
This chapter will help you gain Middle East Market Analysis of Medical Cannabis. Further deep in this chapter, you will be able to review Middle East Medical Cannabis Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
-
7.1 Africa Medical Cannabis Market Size 2021 - 2033
-
7.1.1 Africa Medical Cannabis Market Size By Country 2021 - 2033
-
7.1.2 Africa Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
7.1.2.1 Africa Cannabidiol (CBD) Market Size
-
7.1.2.2 Africa Tetrahydrocannabinol (THC) Market Size
-
7.1.2.3 Africa Others Market Size
-
-
7.1.3 Africa Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
7.1.3.1 Africa Mental Health Management Market Size
-
7.1.3.2 Africa Neurological Disorders Management Market Size
-
7.1.3.3 Africa Pain Management Market Size
-
-
7.1.4 Africa Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
7.1.4.1 Africa Nasal Market Size
-
7.1.4.2 Africa Oral Market Size
-
7.1.4.3 Africa Others Market Size
-
-
7.1.5 Africa Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
7.1.5.1 Africa Hospital Pharmacies Market Size
-
7.1.5.2 Africa Retail Pharmacies Market Size
-
7.1.5.3 Africa Online Pharmacies Market Size
-
-
-
7.2 Nigeria Medical Cannabis Market Size 2021 - 2033
-
7.2.1 Nigeria Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
7.2.2 Nigeria Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
7.2.3 Nigeria Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
7.2.4 Nigeria Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
7.3 South Africa Medical Cannabis Market Size 2021 - 2033
-
7.3.1 South Africa Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
7.3.2 South Africa Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
7.3.3 South Africa Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
7.3.4 South Africa Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
-
7.4 Rest of Africa Medical Cannabis Market Size 2021 - 2033
-
7.4.1 Rest of Africa Medical Cannabis Market Size by Derivative Outlook: 2021 - 2033
-
7.4.2 Rest of Africa Medical Cannabis Market Size by Application Outlook: 2021 - 2033
-
7.4.3 Rest of Africa Medical Cannabis Market Size by Route of Administration Outlook: 2021 - 2033
-
7.4.4 Rest of Africa Medical Cannabis Market Size by Distribution Channel Outlook: 2021 - 2033
-
This chapter provides an in-depth analysis of the market share among key competitors of Medical Cannabis. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2024
-
8.1.2 Global Medical Cannabis Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability) Sample Format
-
8.2.1 Canopy Growth Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 United Cannabis
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Aurora Cannabis
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Cannabis Sativa
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Emerald Health Therapeutics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 GW Pharmaceuticals plc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Tilray
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Medical Marijuana
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 The Supreme Cannabis Company
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 The Cronos Group
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Impact of Trump's Tariff War on Medical Cannabis Market
-
9.1.1 Policy Shifts That Influence the Medical Cannabis Market
-
9.1.2 Tariff and their Long-Term Impact on the Medical Cannabis Market
-
9.1.3 Trade Wars and Supply Chain Changes in the Medical Cannabis Market
-
9.1.4 Regional and Geopolitical implications in the Medical Cannabis Market
-
9.1.5 Tax Reforms and Business Expansion in the Medical Cannabis Market
-
9.1.6 Investor Sentiment in Key Segments of the Medical Cannabis Market
-
9.1.7 Environmental Rollbacks and ESG Implications in the Medical Cannabis Market
-
9.1.8 Consumer Behavior and Brand Perception in the Politicized in Medical Cannabis Market
-
9.1.9 Strategic takeaways for future administration in Medical Cannabis Market
-
-
9.2 Market Drivers
-
9.3 Market Restraints
-
9.4 Market Trends
-
9.5 Market Opportunity
-
9.6 Technological Road Map (Subject to Data Availability)
-
9.7 Product Life Cycle (Subject to Data Availability)
-
9.8 Consumer Preference Analysis
-
9.9 Market Attractiveness Analysis
-
9.10 PESTEL Analysis
-
9.10.1 Political Factors
-
9.10.2 Economic Factors
-
9.10.3 Social Factors
-
9.10.4 Technological Factors
-
9.10.5 Legal Factors
-
9.10.6 Environmental Factors
-
-
9.11 Industrial Chain Analysis (Subject to Data Availability)
-
9.11.1 Industry Chain Analysis
-
9.11.2 Manufacturing Cost Analysis
-
9.11.3 Supply Side Analysis
-
9.11.3.1 Raw Material Analysis
-
9.11.3.2 Raw Material Procurement Analysis
-
9.11.3.3 Raw Material Price Trend Analysis
-
-
-
9.12 Porter’s Five Forces Analysis
-
9.12.1 Bargaining Power of Suppliers
-
9.12.2 Bargaining Power of Buyers
-
9.12.3 Threat of New Entrants
-
9.12.4 Threat of Substitutes
-
9.12.5 Degree of Competition
-
-
9.13 Patent Analysis (Subject to Data Availability)
-
9.14 ESG Analysis
Segmentation Derivative Outlook: Analysis 2019 -2031, will provide market size split by Derivative Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Derivative Outlook: Analysis 2021 - 2033
-
10.1 Cannabidiol (CBD)
-
10.1.1 Global Medical Cannabis Revenue Market Size and Share by Cannabidiol (CBD) 2021 - 2033
-
-
10.2 Tetrahydrocannabinol (THC)
-
10.2.1 Global Medical Cannabis Revenue Market Size and Share by Tetrahydrocannabinol (THC) 2021 - 2033
-
-
10.3 Others
-
10.3.1 Global Medical Cannabis Revenue Market Size and Share by Others 2021 - 2033
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Outlook: Analysis 2021 - 2033
-
11.1 Mental Health Management
-
11.1.1 Global Medical Cannabis Revenue Market Size and Share by Mental Health Management 2021 - 2033
-
-
11.2 Neurological Disorders Management
-
11.2.1 Global Medical Cannabis Revenue Market Size and Share by Neurological Disorders Management 2021 - 2033
-
-
11.3 Pain Management
-
11.3.1 Global Medical Cannabis Revenue Market Size and Share by Pain Management 2021 - 2033
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Route of Administration Outlook: Analysis 2021 - 2033
-
12.1 Nasal
-
12.1.1 Global Medical Cannabis Revenue Market Size and Share by Nasal 2021 - 2033
-
-
12.2 Oral
-
12.2.1 Global Medical Cannabis Revenue Market Size and Share by Oral 2021 - 2033
-
-
12.3 Others
-
12.3.1 Global Medical Cannabis Revenue Market Size and Share by Others 2021 - 2033
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Distribution Channel Outlook: Analysis 2021 - 2033
-
13.1 Hospital Pharmacies
-
13.1.1 Global Medical Cannabis Revenue Market Size and Share by Hospital Pharmacies 2021 - 2033
-
-
13.2 Retail Pharmacies
-
13.2.1 Global Medical Cannabis Revenue Market Size and Share by Retail Pharmacies 2021 - 2033
-
-
13.3 Online Pharmacies
-
13.3.1 Global Medical Cannabis Revenue Market Size and Share by Online Pharmacies 2021 - 2033
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Medical Cannabis market
Chapter 14 Research Findings
-
14.1 Key Takeaways
-
14.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
14.3 Assumptions and Acronyms
Chapter 15 Research Methodology and Sources
-
15.1 Primary Data Collection
-
15.1.1 Steps for Primary Data Collection
-
15.1.1.1 Identification of KOL
-
-
15.1.2 Backward Integration
-
15.1.3 Forward Integration
-
15.1.4 How Primary Research Help Us
-
15.1.5 Modes of Primary Research
-
-
15.2 Secondary Research
-
15.2.1 How Secondary Research Help Us
-
15.2.2 Sources of Secondary Research
-
-
15.3 Data Validation
-
15.3.1 Data Triangulation
-
15.3.2 Top Down & Bottom Up Approach
-
15.3.3 Cross check KOL Responses with Secondary Data
-
-
15.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1 Data Gathering
- 1.1 Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.1.1.1 Identification of KOL
- 1.1.1.2 Backward Integration
- 1.1.1.3 Forward Integration
- 1.1.1.4 How Primary Research Help Us
- 1.1.1.5 Modes of Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.2 Secondary Research
- 1.2.1 How Secondary Research Help Us
- 1.2.2 Sources of Secondary Research
- 1.1 Primary Research
- 2 Data Validation
- 2.1 Cross check KOL Responses with Secondary Data
- 2.2 Top Down & Bottom Up Approach
- 2.3 Data Triangulation
- 3 Data Representation
Key Questions Answered By Medical Cannabis Market Report 2025
| Why Cannabidiol (CBD) have a significant impact on Medical Cannabis market? |
| What are the key factors affecting the Cannabidiol (CBD) and Tetrahydrocannabinol (THC) of Medical Cannabis Market? |
| What is the CAGR/Growth Rate of Mental Health Management during the forecast period? |
| By type, which segment accounted for largest share of the global Medical Cannabis Market? |
| Which region is expected to dominate the global Medical Cannabis Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
